Family creates walk to support mother diagnosed with autoimmune condition in February ...

The actor, who died Sunday at age 65, was an "irreplaceable" part of the Scleroderma Research Foundation, says chairman Luke Evnin Julie Mazziotta is the Senior Sports Editor at PEOPLE, covering ...

Fans of Bob Saget are mourning his death this week. Joining the list of celebs and fans pouring out tributes to the "Full House" TV star and comedian is the Scleroderma Research Foundation (SRF).

According to the Mayo Clinic, the condition involves the hardening and tightening of the skin, and there is no cure.

Now patients, caregivers and healthcare professionals have an easy and effective way to search and match to scleroderma clinical trials. DANVERS, MA and RALEIGH, NC / ACCESSWIRE / June 14, 2023 / ...

Bob Saget was a tireless activist for the Scleroderma Research Foundation, inspired by the death of his sister, Gay Bob Saget was all about the jokes. But his family life was anything but funny. In ...

The Scleroderma Research Foundation (SRF)—the country’s first and leading nonprofit investor in medical research into scleroderma—announced a $1.5 million dollar matching gift, in the form of a grant ...

Last week, in a special evening honoring John Mayer and Jeff Ross, Cool Comedy • Hot Cuisine raised more than $1.3 million for the Scleroderma Research Foundation (SRF)—the country’s first and leading ...

Please provide your email address to receive an email when new articles are posted on . In a world where potentially fatal, high-profile diseases like breast cancer and diabetes devour resources and ...

A doctor has revealed four symptoms, when combined, could point to a rare autoimmune disease many people don’t realize they ...

DANVERS, Mass.--(BUSINESS WIRE)--The Scleroderma Foundation, a national nonprofit that advances medical research, promotes disease awareness and provides support and education to people with ...

MONTREAL, January 27, 2026--(BUSINESS WIRE)--Indero is pleased to announce a strategic collaboration with the World Scleroderma Foundation (WSF) to support WSF SHIELD platform trial, a randomized, ...